Screening for mutations of the APC gene in 66 Italian familial adenomatouspolyposis patients: Evidence for phenotypic differences in cases with and without identified mutation
M. Giarola et al., Screening for mutations of the APC gene in 66 Italian familial adenomatouspolyposis patients: Evidence for phenotypic differences in cases with and without identified mutation, HUM MUTAT, 13(2), 1999, pp. 116-123
Germline mutations in the APC gene are responsible for familial adenomatous
polyposis (FAP), a dominantly inherited syndrome characterized by the deve
lopment of hundreds to thousands of polyps in the colon and in the rectum o
f affected individuals and by variable extracolonic manifestations (gastric
and duodenal polyps, osteomas, retinal lesions, and desmoid tumors). Throu
gh the combined use of single strand conformation polymorphism (SSCP) analy
sis and the protein truncation test (PTT), we have screened 66 Italian FAP
patients and found 29 different APC mutations in a total of 34 cases. Of th
e identified mutations, 15 were nonsense, 12 were 1- to 5-bp deletions or i
nsertions and two were complex rearrangements, all leading to the formation
of premature stop codons. Only 10 mutations had been already previously de
scribed at the germline level, confirming the high heterogeneity of the APC
mutational spectrum. The mean age of diagnosis in mutation positive cases
and their affected relatives was significantly lower than in cases without
identified mutation (30.6 vs 39.1 years, respectively; p = 0.003). In addit
ion, among patients without a family history of polyposis, all mutation pos
itive cases displayed at least one of the extracolonic manifestations usual
ly associated with FAP, whereas in one-half of the cases without identified
mutation, none of these phenotypes was observed. Although a fraction of ap
parently mutation-negative cases were likely to be due to limitations of th
e mutation screening strategy our results suggest, in agreement with previo
us reports, that allelic and/or genetic heterogeneity might be responsible
for the phenotypic variability observed in FAP patients. Hum Mutat 13:116-1
23, 1999. (C) 1999 Wiley-Liss, Inc.